Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII‐induced angiogenesis by inte...
Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII‐induced angiogenesis by interacting with IRE1 in its active conformation
About this item
Full title
Author / Creator
Publisher
Australia: Wiley Subscription Services, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Australia: Wiley Subscription Services, Inc
Subjects
More information
Scope and Contents
Contents
Angiotensin II (AngII)‐mediated pathological angiogenesis is one of the important factors promoting the progression of atherosclerosis, tumour metastasis, and diabetic retinopathy. Here, we first demonstrate that salvianolic acid B (Sal B) attenuated AngII‐induced angiogenesis by downregulating the IRE1/ASK1/JNK/p38MAPK signalling pathway and prote...
Alternative Titles
Full title
Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII‐induced angiogenesis by interacting with IRE1 in its active conformation
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2747978287
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2747978287
Other Identifiers
ISSN
0305-1870
E-ISSN
1440-1681
DOI
10.1111/1440-1681.13726
